Background: Transanal endoscopic microsurgery (TEM) was originally designed for local endoscopic excision of benign and low-grade mucosal rectal lesions through an endoscopic system. The procedure is particularly challenging for submucosal and retrorectal lesions, as the tumor margins are not well defined.
R
etrorectal and submucosal rectal lesions that require surgery are often approached through the abdomen or the perineum, depending on the nature and location of the lesion. When high in the rectum, an anterior abdominal approach is required. Lesions below S3 can be reached by a posterior approach (transsacrally or transcoccygeally). Both the approaches are considered as major surgery, and may be associated with a prolonged recovery period and high morbidity rate. 1, 2 Interest has therefore increased for the search of approaches that can achieve comparable oncologic outcomes with lower morbidity and shorter recovery time.
Transanal endoscopic microsurgery (TEM) was designed for the excision of benign and low-grade malignant rectal tumors. [3] [4] [5] The procedure is performed within a small rectal space that is inflated by carbon dioxide to facilitate maneuvering. 6 Precision and clear visibility of the tumor margins is critical for optimal resection. Therefore, as the margins of retrorectal and submucosal lesions are not well defined, their treatment by TEM is particularly challenging.
We present the experience of 1 medical center with TEM resection of retrorectal and submucosal lesions, describing the approach, its feasibility, and outcomes.
PATIENTS AND METHODS
All patients at our department of general surgery who underwent TEM for retrorectal or rectal submucosal lesions, based on the postoperative histopathology findings, during an 11-year period (2001 to 2011) were identified, and their data retrieved. All the procedures were performed by a single surgeon. Patient charts were reviewed and data pertaining to demographic characteristics and preoperative tumor characteristics were collected. In all cases, tumors were evaluated preoperatively by rigid proctoscopy and transrectal ultrasound. For large tumors, a metastatic work up was also performed. Patients were eligible for TEM if the tumor was small, located at mid or low rectum, did not penetrate adjacent organs, and a metastatic spread was excluded.
Intraoperative findings and complications, as well as the duration of surgery, type of anesthesia, and type of postoperative analgesia were retrieved. To evaluate the adequacy of the technique by which tumors were resected, in terms of complete resection and tumor-free margins, the final histopathologic reports were also reviewed.
Data pertaining to postoperative morbidity, including bleeding, urinary retention, and infections (pararectal abscesses, pulmonary, and urinary tract infections); length of hospital stay (LOS); and the need for reoperation or readmission were also collected. Data regarding overall complications and oncologic outcomes, including local and distant recurrence and survival, were accessed from records of comprehensive follow-up visits that were held every 3 months during the first 2 postoperative years and every 6 months thereafter, for a maximum of 5 years. It includes a rectal exam and rigid proctoscopy. If any suspicious 
RESULTS
Fifteen patients (5 females, 10 males) underwent TEM for retrorectal or submucosal rectal lesions. Their demographic and medical data are reported in Table 1 . All procedures were completed endoscopically. The median distance of the tumor from the anal verge was 7.3 cm (range, 5 to 10 cm), and the mean diameter was 3 ± 1.1 cm. Preoperative rigid proctoscopy detected a tumor bulge with an intact mucosa in all the patients, whereas transrectal ultrasound revealed a submucosal rectal lesion in 11 patients, and retrorectal cysts without septations or wall abnormalities in the other 4 ( Table 1 ). Lipomas were removed if they are symptomatic. Tumor characteristics for each individual are listed in Table 2 .
All lesions were completely excised without penetrating the tumor capsule. However, microscopically involved margins were documented in 1 patient with a gastrointestinal stromal tumor (GIST); for whom free margins were later confirmed after reoperation by TEM. The median operative time was 67 ± 54 minutes. No intraoperative complications were documented. Thirteen of the 15 procedures were performed with spinal anesthesia. No intravenous or intramuscular analgesic medications were indicated for postoperative pain alleviation.
Postoperative complications were few. One patient experienced urinary tract infection, and a second experienced fever and bloody discharge. The mean LOS was 1.85 ± 1.77 days. No early readmissions were documented. After a median follow-up of 20 months (range, 6 to 30 mo), no local or systemic recurrence was identified.
DISCUSSION
We report complete tumor excision in 14 of 15 patients. For the remaining patient, repeat TEM was effective in achieving oncologically free margins. The low morbidity rate and short LOS support a previous report of negligible post-TEM morbidity. 7 Notably, comparing the TEM-associated morbidity to that of other traditional approaches, such as anterior resection of the rectum, 8, 9 further potentiates the benefits of TEM over other techniques. Of note, the possibility of introducing infection to a sterile space by transrectal surgery and extraction is an issue to be considered, it might affect outcomes with larger scale studies.
We considered retrorectal and submucosal rectal lesions together because identification of tumor margins by direct vision is difficult in both. Because generally, only a bulge with an intact rectal mucosa can be seen, the capability of treating these tumors endoscopically is limited. Despite the challenge, the TEM technique is an option that precludes major abdominal procedures in the treatment of such tumors.
In the current study, several types of submucosal rectal tumors were indications for TEM, of them GIST was the most common. Complete surgical resection with negative tumor margins is considered the treatment of choice. [10] [11] [12] Surgical management of rectal GISTs depends on the preoperative diagnosis, tumor location, size, and extent of the disease. [10] [11] [12] All lesions larger than 2 cm should be resected, because of their potential of malignancy. The range of GIST size in the current series was 2 to 5 cm, thus indicating local excision. TEM was our preferred approach as traditional rectal resections are too radical for low-grade malignant GISTs, and also because lymph node metastases of GISTs are rare. Because of the latter, conventional anterior resection with total mesorectal excision is not justified. Although its use for the resection of rectal GISTs has rarely been reported, 13, 14 TEM seems to be a feasible and safe approach for these tumors, and should be considered in selected patients with small-sized and intermediate-sized rectal GISTs.
Other submucosal lesions in the present study included neurinomas and carcinoid tumors. There are no limiting factors for local excision of neurinomas except for the size and the location. 15 The appropriate treatment for rectal carcinoids, measuring 1 to 2 cm, as in our patients, is controversial, because the biological behavior of these tumors is unpredictable. Such features as high mitotic rate, undifferentiated appearance, invasion of the muscularis propria, and lymphatic or vascular invasion, all mandate formal rectal resection. 16, 17 None of these features presented in the patients in the present report, who all underwent local resection by means of the TEM technique. Although the types of submucosal lesions reviewed herein can also be treated by a traditional transanal approach, TEM allows for a full-thickness resection with wide margins and an intact capsule in tumors up to 10 to 12 cm in proximity to the anal verge. This ensures free surgical margins, as was seen in our series, thus further supporting TEM use over other available techniques.
Four of our patients underwent surgery for retrorectal lesions consistent with tailgut cysts-enterogenous cyst. The definitive diagnosis and treatment of a tailgut cyst is achieved through complete surgical excision. 17, 18 Biopsy should be avoided if possible. To prevent recurrence, infection, and a rare malignant transformation, complete excision is recommended. TEM is an optimal approach for the excision of a tailgut cyst, obviating more extensive operations, such as the Kraske procedure. Although not fully endorsed, TEM for retrorectal tumors might be superior to other approaches because of the combination of the high 3-dimensional view and the 6-fold magnification of the operative site. With establishment of a stable pneumorectum, and the use of specially designed instruments, the mass excision through the rectal wall is highly accurate, thus enabling safe histologic results.
The current series demonstrates an additional advantage of TEM over other surgical approaches; it enables complete excision of tumors under spinal anesthesia. The advantages of spinal anesthesia over general anesthesia are well documented from neuropharmacological and analgesic aspects. 19, 20 The fact that a single injection or continuous spinal anesthesia affords ample time for operative work is of great benefit. Further, the analgesia enables prolonged postoperative antinociception, which is optimal for early rehabilitation and does not cause opioid-associated intestinal disturbances.
The retrospective design and lack of a comparative group are the limitations of this study. Only 15 operations occurred during the 11-year study period, with a variety of indications for surgery. Further, the relatively short-term follow-up, averaged at 20 months, may not be long enough to assess the long-term effectiveness of resection and lack of recurrence. Nevertheless, the free margins that resulted in all but one case (92.3%) indicate the technique's effectiveness. Larger scale studies are required to further validate this contention.
In summary, TEM in skilled hands is a conservative, safe, and feasible option for selected submucosal rectal and retrorectal masses with low risk for perioperative morbidity and mortality. It seems an effective substitute to traditional approaches for such tumors. Additional clinical studies are needed to further demonstrate its acceptability on a large scale.
